Drugs / TMZ
last change May 2016 re-read 2 minutes ago

TMZ

Developed for
glioma

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00727506 Comparator Jul 2008 → May 2011 glioma Boehringer Ingelheim Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as TMZ ClinicalTrials.gov intervention name — accepted as the source's own label NCT00727506